Abbott’s strong medical devices sales boosted the company during the first part of 2024, beating Wall Street expectations and raising its forward-looking financial guidance.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,